We are live on ! Find out more
NBIX icon

Neurocrine Biosciences
NBIX

133 hedge funds and large institutions have $1.88B invested in Neurocrine Biosciences in 2014 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 44 increasing their positions, 42 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more capital invested

Capital invested by funds: $1.05B → $1.88B (+$836M)

73% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 11

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

13% more call options, than puts

Call options by funds: $20M | Put options by funds: $17.7M

6% more funds holding

Funds holding: 125 → 133 (+8)

5% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 42

Holders
133
Holders Change
+8
Holders Change %
+6.4%
% of All Funds
3.86%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
19
Increased
44
Reduced
42
Closed
11
Calls
$20M
Puts
$17.7M
Net Calls
+$2.3M
Net Calls Change
-$709K

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$16.7M
2
Citadel Advisors
Citadel Advisors
Florida
+$9.97M
3
FAM
Fred Alger Management
New York
+$8.9M
4
CAM
Cormorant Asset Management
Massachusetts
+$8.22M
5
TCM
Tekla Capital Management
Massachusetts
+$7.35M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$5.47M
2
GPP
Great Point Partners
Connecticut
-$5.24M
3
TI
Turner Investments
Pennsylvania
-$4.51M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$4.06M
5
Aviva
Aviva
United Kingdom
-$1.85M
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
51
Barclays
United Kingdom
$2.29M +$1.59M +106,580 +233%
California State Teachers Retirement System (CalSTRS)
52
California State Teachers Retirement System (CalSTRS)
California
$2.2M +$25.3K +1,695 +1%
QBFM
53
QS Batterymarch Financial Management
New York
$2.17M -$195K -13,030 -9%
AllianceBernstein
54
AllianceBernstein
Tennessee
$1.97M – – –
BlackRock
55
BlackRock
New York
$1.76M -$133K -8,900 -7%
TA
56
Teachers Advisors
New York
$1.63M -$56.8K -3,800 -4%
California Public Employees Retirement System
57
California Public Employees Retirement System
California
$1.62M – – –
AIG
58
American International Group
New York
$1.61M +$99.9K +6,684 +7%
UOC
59
UBS O'Connor
Illinois
$1.57M +$523K +35,000 +54%
GTC
60
Ghost Tree Capital
New York
$1.57M +$1.49M +100,000 New
Wells Fargo
61
Wells Fargo
California
$1.54M +$203K +13,589 +16%
EAM
62
Eventide Asset Management
Massachusetts
$1.51M – – –
ZDA
63
Zweig-DiMenna Associates
New York
$1.46M -$479K -32,024 -26%
Prudential Financial
64
Prudential Financial
New Jersey
$1.39M -$127K -8,477 -9%
Swiss National Bank
65
Swiss National Bank
Switzerland
$1.28M -$28.4K -1,900 -2%
PAM
66
Paradigm Asset Management
New York
$1.18M +$1.13M +75,400 New
RhumbLine Advisers
67
RhumbLine Advisers
Massachusetts
$1.13M +$19.9K +1,330 +2%
AQR Capital Management
68
AQR Capital Management
Connecticut
$1.12M -$1.83M -122,400 -63%
State Board of Administration of Florida Retirement System
69
State Board of Administration of Florida Retirement System
Florida
$1.1M – – –
ProShare Advisors
70
ProShare Advisors
Maryland
$1.08M -$206K -13,771 -17%
American Century Companies
71
American Century Companies
Missouri
$1.04M +$47.4K +3,174 +5%
DCM
72
DAFNA Capital Management
California
$1.04M +$989K +66,141 New
VFA
73
Virtus Fund Advisers
Connecticut
$1.01M -$90K -6,020 -9%
SO
74
STRS Ohio
Ohio
$965K +$398K +26,600 +76%
DBG
75
De Burlo Group
Massachusetts
$964K -$35.9K -2,400 -4%
1 2
3
4 5

NBIX Hedge Fund Activity: Q3 2014 in Review

133 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Neurocrine Biosciences (NBIX) for Q3 2014, worth a combined $1.88B — up 80% from $1.05B a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new NBIX positions and 11 closed out — a net gain of 8 holders — while 44 added to existing stakes and 42 trimmed.

The largest buyer was OrbiMed, adding an estimated $16.7M. The largest seller was Franklin Resources, cutting an estimated $5.47M.

  • 133 institutional investors held Neurocrine Biosciences (NBIX) as of Q3 2014, up from 125 in Q2 2014.
  • Funds reported $1.88B of Neurocrine Biosciences stock for Q3 2014, up 80% quarter-over-quarter.
  • 19 funds opened new Neurocrine Biosciences positions in Q3 2014 and 11 closed out, a net change of +8 holders.
  • The largest Neurocrine Biosciences buyer in Q3 2014 was OrbiMed, an estimated $16.7M added.
  • The largest Neurocrine Biosciences seller in Q3 2014 was Franklin Resources, an estimated $5.47M sold.

Based on aggregated 13F filings for Q3 2014.